Analysis of the necessary radioprotection procedures in manufacture of iodine-125 sources used in brachytherapy: A preliminary study

被引:1
|
作者
Souza, Carla D. [1 ]
Rostelato, Maria Elisa C. M. [1 ]
Zeituni, Carlos A. [1 ]
Moura, Joao A. [1 ]
Moura, Eduardo S. [1 ]
Fonseca, Katia [1 ]
Feher, Anselmo [1 ]
机构
[1] IPEN, CNEN, SP, BR-05508000 Sao Paulo, Brazil
关键词
Prostate cancer; Brachytherapy; Iodine-125; Radioactive installation; Radiation protection; Dosimetry; PROSTATE-CANCER; SILVER; EYE;
D O I
10.1016/j.pnucene.2010.08.011
中图分类号
TL [原子能技术]; O571 [原子核物理学];
学科分类号
0827 ; 082701 ;
摘要
The estimates for the year 2009 predict that 466,730 new cancer cases would occur in Brazil. Prostate cancer is the second most incident in our country, with almost 50,000 new cases in 2009. Brachytherapy, a type of radiotherapy. with iodine-125 sources is an important form of treatment for this kind of cancer. The "Instituto de Pesquisas Energeticas e Nucleares" (Institute for Nuclear and Energy Research - IPEN) created a project to produce a national prototype of these sources and develop a facility for local production. Manufacturing seeds locally will diminish the overall treatment cost making such treatment available to a larger number of patients. While the laboratory is under development, the IPEN imports and distributes seeds. This work aims to present and evaluate the radiological protection procedures applied to imported sources in order to assist in the setup of the new laboratory. Although iodine-125 presents low energy photons, around 29 key, local and personal dosimeters are used during the separation and distribution process of seeds as described in CNEN NN 3.01 standard "Diretrizes Basicas de Protecao Radiologica" (Radiological Protection Basic Guidelines). All testing has demonstrated that there is no area contamination and very low exposure, suggesting that the application of the standards outlined in CNEN NN 3.01 has been effective. As a result of this work, a new dosimeter should be installed and evaluated in a future study. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 39 条
  • [1] Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis
    Raleigh, David R.
    Seymour, Zachary A.
    Tomlin, Bryan
    Theodosopoulos, Philip V.
    Berger, Mitchel S.
    Aghi, Manish K.
    Geneser, Sarah E.
    Krishnamurthy, Devan
    Fogh, Shannon E.
    Sneed, Penny K.
    McDermott, Michael W.
    JOURNAL OF NEUROSURGERY, 2017, 126 (06) : 1749 - 1755
  • [2] Iodine-125 brachytherapy for a desmoid tumor in the abdomen-thorax: A retrospective study
    Chuang, He
    Xiao-Han, Huang
    Li, Liu
    Dong-Yuan, Li
    Liang-Shan, Li
    Ting-Yuan, Li
    Qing-Hua, Liang
    He-Nan, Liu
    Wei, Li
    Xue-Quan, Huang
    BRACHYTHERAPY, 2023, 22 (06) : 851 - 857
  • [3] Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
    Beydoun, Nadine
    Bucci, Joseph
    Malouf, David
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2014, 6 (01) : 15 - 20
  • [4] Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
    Teixeira Leite, Elton Trigo
    Fernandes da Silva, Joao Luis
    Capelletti, Eduardo
    Kalil Haddad, Cecilia Maria
    Marta, Gustavo Nader
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 288 - 298
  • [5] Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants
    Usmani, Nawaid
    Chng, Nick
    Spadinger, Ingrid
    Morris, W. James
    BRACHYTHERAPY, 2011, 10 (04) : 275 - 285
  • [6] The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy
    Katsumi Hirose
    Masahiko Aoki
    Mariko Sato
    Hiroyoshi Akimoto
    Yasuhiro Hashimoto
    Atsushi Imai
    Noritaka Kamimura
    Hideo Kawaguchi
    Yoshiomi Hatayama
    Ichitaro Fujioka
    Mitsuki Tanaka
    Chikara Ohyama
    Yoshihiro Takai
    Japanese Journal of Radiology, 2016, 34 : 718 - 723
  • [7] PROSTATE-SPECIFIC ANTIGEN BOUNCE AFTER PERMANENT IODINE-125 PROSTATE BRACHYTHERAPY-AN AUSTRALIAN ANALYSIS
    Zwahlen, Daniel R.
    Smith, Ryan
    Andrianopoulos, Nick
    Matheson, Bronwyn
    Royce, Peter
    Millar, Jeremy L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (01): : 179 - 187
  • [8] The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy
    Hirose, Katsumi
    Aoki, Masahiko
    Sato, Mariko
    Akimoto, Hiroyoshi
    Hashimoto, Yasuhiro
    Imai, Atsushi
    Kamimura, Noritaka
    Kawaguchi, Hideo
    Hatayama, Yoshiomi
    Fujioka, Ichitaro
    Tanaka, Mitsuki
    Ohyama, Chikara
    Takai, Yoshihiro
    JAPANESE JOURNAL OF RADIOLOGY, 2016, 34 (11) : 718 - 723
  • [9] Quantitative analysis of genitourinary toxicity after iodine-125 brachytherapy for localized prostate cancer: Followup of the International Prostate Symptom Score and Overactive Bladder Symptom Score
    Sakayori, Masanori
    Ohashi, Toshio
    Momma, Tetsuo
    Kaneda, Tomoya
    Nishimura, Shuichi
    Sutani, Shinya
    Yamashita, Shoji
    Shigematsu, Naoyuki
    BRACHYTHERAPY, 2017, 16 (04) : 806 - 814
  • [10] Outcomes following iodine-125 brachytherapy in patients with Gleason 7, intermediate risk prostate cancer: A population-based cohort study
    Herbert, Christopher
    Morris, W. James
    Keyes, Mira
    Hamm, Jeremy
    Lapointe, Vincent
    McKenzie, Michael
    Pickles, Thomas
    Spadinger, Ingrid
    RADIOTHERAPY AND ONCOLOGY, 2012, 103 (02) : 228 - 232